Floating-Harbor syndrome (FHS) is a rare inherited developmental disorder characterized by bone mineralization delay and growth deficits frequently associated with skeletal and craniofacial defects and mental retardation. The major cause of FHS is heterozygous truncating mutations in Srcap, which encodes the ATPase SRCAP, the core catalytic subunit of the homonymous multiprotein chromatin-remodeling complex in humans. This complex promotes the exchange of canonical histone H2A with the H2A.Z variant. SRCAP is also implicated in several cellular processes, but the molecular basis of FHS still needs to be elucidated. Using a combined approach, we studied the involvement of SRCAP in cell cycle progression in HeLa cells. In addition to the canonical localization in interphase nuclei, both SRCAP and its Drosophila orthologue localized to the mitotic apparatus after nuclear envelope breakdown, and their depletion impaired mitosis progression and cytokinesis in human and Drosophila cells, respectively. Importantly, SRCAP interacted with cytokinesis regulators and α-Tubulin during telophase, strongly supporting a direct role in cytokinesis, independent of its chromatin remodeling functions. Our results provide clues about previously undetected, evolutionarily conserved roles of SRCAP in ensuring proper mitosis and cytokinesis. We propose that perturbations in cell division contribute to the onset of developmental defects characteristic of FHS.